LasB-IN-1
Product Specifications
UNSPSC Description
LasB-IN-1 (compound 5f) is a potent and orally active inhibitor of LasB (IC50 = 8.7 μM). LasB-IN-1 effectively attenuates elastase production and biofilm formation by P. aeruginosa while alleviating the inflammatory response through downregulating MAPK and NF-κB pathways. LasB-IN-1 is potential to be a novel anti-infective candidate against drug-resistant infections[1].
Target Antigen
Bacterial; Elastase; NF-κB; p38 MAPK
Type
Reference compound
Related Pathways
Anti-infection;MAPK/ERK Pathway;Metabolic Enzyme/Protease;NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/lasb-in-1.html
Solubility
10 mM in DMSO
Smiles
O=C1N(CC2=CC=C(C(F)(F)F)C=C2)C(O)(CCCC)C3=C1C=CCC3
Molecular Weight
365.39
References & Citations
[1]Ping-Hua Sun, et al. Novel ligustilide derivatives target quorum sensing system LasR/LasB and relieve inflammatory response against Pseudomonas aeruginosa infection. European Journal of Medicinal Chemistry. 2023，263，115972.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-163030/LasB-IN-1-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-163030/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
26300141 1x10<sup>6</sup> cells/1.0ml
LAPTM4A CRISPR Knock Out 293T Cell Line (Human)
Ask
View Details 